Furthermore, TMB, MSI, MMR, DNA methylation, and RNA modification play a significant role in mediating MPZL3 dysregulation in cancers, and MPZL3 is closely linked to tumor immunity and acts as a suitable target for antitumor immunity therapeutics. Here, MPZL3 is linked to neoplasm.